The overall objective of this multidisciplinary patient oriented Program Project is to determine the role of mitochondrial dysfunction in the pathogenesis of insulin resistance and other related metabolic disorders in humans. All three projects in the Program entail recruitment and characterization of patients with mitochondrial abnormalities for metabolic characterization and genetic studies. In the Clinical Core volunteer recruitment, and screening will be centralized. The Core will provide specialized clinical support for magnetic resonance and stable isotope infusion studies for each of the studies under this Program Project. By centralizing this core we will be able to provide the highest level of technical and clinical expertise required for these magnetic resonance infusion and clamp studies as well as increased efficiency by eliminating duplication. Specifcally this core will: (I) screen, recruit and perform hyperinsulinemic-euglycemic clamp studies in young lean insulin resistant offspring and age-weight-activity matched control subjects and patients with mt tRNA mutations for Projects 1, 2, 3, (II) screen and recruit patients with a known mitochondrial tRNA mutation that is associated with hypertension for projects 1, 2, 3 and (III)screen and recruit healthy elderly subjects for project 3. In addition this core will provide specialized clinical support for stable isotope infusion studies that will be performed inside the 4.0T magnetic resonance spectrometer in order to assess tissue specific rates of mitochondrial activitiy in muscle, liver and brain for Projects 1,2 & 3. This clinical core is thus an essential resource that is required to complete the research proposed in Projects 1,2 & 3.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
New Haven
United States
Zip Code
Madiraju, Anila K; Qiu, Yang; Perry, Rachel J et al. (2018) Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nat Med 24:1384-1394
Lee, Hui-Young; Gattu, Arijeet K; Camporez, João-Paulo G et al. (2014) Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice. Diabetologia 57:1232-41
Jornayvaz, François R; Shulman, Gerald I (2012) Diacylglycerol activation of protein kinase C? and hepatic insulin resistance. Cell Metab 15:574-84
Samuel, Varman T; Shulman, Gerald I (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148:852-71
Samuel, Varman T; Petersen, Kitt Falk; Shulman, Gerald I (2010) Lipid-induced insulin resistance: unravelling the mechanism. Lancet 375:2267-77
Petersen, Kitt Falk; Dufour, Sylvie; Hariri, Ali et al. (2010) Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med 362:1082-9
Boumezbeur, Fawzi; Mason, Graeme F; de Graaf, Robin A et al. (2010) Altered brain mitochondrial metabolism in healthy aging as assessed by in vivo magnetic resonance spectroscopy. J Cereb Blood Flow Metab 30:211-21
Boumezbeur, Fawzi; Petersen, Kitt F; Cline, Gary W et al. (2010) The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy. J Neurosci 30:13983-91
Mitchell, Catherine S; Savage, David B; Dufour, Sylvie et al. (2010) Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. J Clin Invest 120:1345-54
Befroy, Douglas E; Falk Petersen, Kitt; Rothman, Douglas L et al. (2009) Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy. Methods Enzymol 457:373-93

Showing the most recent 10 out of 30 publications